Once-Daily, Enteric-Coated Videx sNDA Has Oct. 30 User Fee Deadline
Executive Summary
Bristol Myers Squibb has submitted a supplemental NDA for the antiretroviral drug Videx with once-daily dosing. Filed April 30, the application was granted a six-month priority review ending October 30, the company recently announced.